Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,464,778
-$22,399 QoQ
Shares Held
9,705
-4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#2,173
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WIMMER ASSOCIATES 1, LLC holds $14,096,189 across 8 Drug Manufacturers - General names. JNJ ranks #4 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,574 | $3,164,121 | |
| 2 | AMGN |
Amgen Inc
|
8,431 | $3,053,033 | |
| 3 | LLY |
ELI LILLY & Co
|
2,470 | $2,962,592 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
9,705 | $2,464,778 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,952 | $1,407,332 | |
| 6 | NVS |
Novartis AG
|
2,594 | $406,531 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,110 | $392,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,464,778 | 9,705 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,487,177 | 10,175 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,121,030 | 10,249 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,933,559 | 10,428 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,592,877 | 10,428 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,755,084 | 10,583 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,550,326 | 10,720 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,738,903 | 10,730 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,568,296 | 10,730 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,732,496 | 10,952 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,733,230 | 11,058 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,705,151 | 10,948 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,922,018 | 11,612 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,812,260 | 11,692 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,093,479 | 11,851 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,943,330 | 11,896 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,141,835 | 12,066 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,145,369 | 12,105 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,082,777 | 12,175 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,997,109 | 12,366 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,029,926 | 12,322 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,050,266 | 12,475 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,080,878 | 13,222 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,919,509 | 12,893 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $1,755,484 | 12,483 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,680,037 | 12,812 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||